calculated the incident rate of all fractures. After dividing the patients according to the use of GCs, we compared baseline characteristics and fracture-free survival between two groups. We compared accuracies of TBS, BMD, clinical risk factors for fracture and their combinations for predicting new fractures using areas under the receiver operator characteristic (ROC) curve (AUC). Results: A total of 14 fractures in 12 patients were occurred among 100 patients during follow-up (428.8 person-years): 9 among the 44 in GC users and 5 in 56 GC non-users. Incidence of fracture was not different between two groups (log-rank test, p=0.27). AUC for incident fracture prediction of TBS alone [AUC 0.54, 95% confidence interval (CI) 0.35-0.72] was comparable with TBS combined with L-spine BMD (AUC 0.54, 95% CI 0.36-0.71) or with hip BMD (AUC 0.55, 95% CI 0.37-0.73). Accuracy for prediction of new fracture is increased when TBS was combined with age and history of previous fracture (AUC 0.74, 95% CI 0.62-0.85). In GC users, history of previous fracture alone (AUC 0.79, 95% CI 0.62-0.97) showed the best accuracy for predicting new fracture among TBS, BMD, clinical risk factors for fracture and their combinations. Conclusions: TBS combined with age and previous history of fracture showed the highest accuracy for predicting new fracture compared to TBS or BMD alone or their combinations in RA patients. In GC users, history of previous fracture alone showed the highest accuracy for predicting new fracture.
Background: Bone Mineral density (BMD) assessment is a useful tool to evaluate bone fragility and is largely recommended in patients at risk of osteoporosis. We have previously reported in 250 women aged 50 year-old or more that only ≈10% of them had a BMD after a forearm fracture (1). Objectives: Herein, we evaluated BMD assessment and prescription of antiosteoporotic drugs after a forearm fracture in women after 50 year-old in a large population database. Methods: We identified all forearm fractures in women aged 50 years old or more in the "Centre-Val de Loire, France" area between 01/01/2011 and 31/12/2012, using the National Health Insurance database which cover both private and public sectors of the whole population. We analyzed the reimbursement and determinants of BMD assessment such as age, consumption of drugs inducing osteoporosis, anti-osteoporotics drugs and long term illnesses. Results: We identified 4120 women with a forearm fracture during the study period. Among them, 546 (13.25%) had a BMD assessment performed at a median time of 4 months after the fracture. Women who had had a BMD were significantly yonger than those who had not (67.44 years versus 74.63 years: OR=0.941 CI95% (0.932-0.949)). Anti-aromatase treatment was positively associated with BMD assessment (OR=3.233 (CI95%: 1.976-5.290)) while corticosteroid were not (OR=0.866 (CI95%: 0.601-1.247)). Among the women who had a BMD assessment, 168/546 (30.77%) had an anti-osteoporotic drug initiated after the forearm fracture, versus 231/3574 (6.46%) in those who had no BMD performed (p<0.05).
Conclusions:
In this large population, less than 15 percent of women over 50 year-old have a BMD assessment after a forearm fracture. BMD assessment was associated with anti-osteoporotic drugs initiation. Background: Body composition changes resulting from ageing (decreased muscle mass and increased fat tissue) are frequently not accompanied by concomitant changes in body mass index (BMI). Thus, BMI has low accuracy to estimate death risk attributed to changes in body composition in the older adults 1 . Currently, the best method for body composition analysis in routine clinical practice is dual energy X-ray absorptiometry (DXA) 2 . However, the few studies on body composition by DXA and mortality risk in elderly have some limitations, such as analysis not compartmentalized (subcutaneous and visceral tissues) of body fat and appendicular muscle mass not adjusted for fat mass 3 . Objectives: We sought to investigate the association between body composition by DXA (including visceral fat measurement) and mortality in a longitudinal, prospective, population-based cohort of elderly subjects. Methods: 839 community-dwelling subjects (516 women, 323 men), ≥65 years, were assessed by questionnaire on clinical data, laboratory exams and body composition by DXA using Hologic QDR 4500A equipment. DXA APEX software computes visceral adipose tissue (VAT) by subtracting the subcutaneous adipose tissue (SAT) from the total android fat. All analyses were performed at baseline. Total body fat was expressed by fat mass index (FMI) [(total body fat (kg)/height
